F. Heldmann

1.5k total citations
37 papers, 946 citations indexed

About

F. Heldmann is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, F. Heldmann has authored 37 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 14 papers in Immunology and 7 papers in Hematology. Recurrent topics in F. Heldmann's work include Spondyloarthritis Studies and Treatments (28 papers), Rheumatoid Arthritis Research and Therapies (25 papers) and Psoriasis: Treatment and Pathogenesis (11 papers). F. Heldmann is often cited by papers focused on Spondyloarthritis Studies and Treatments (28 papers), Rheumatoid Arthritis Research and Therapies (25 papers) and Psoriasis: Treatment and Pathogenesis (11 papers). F. Heldmann collaborates with scholars based in Germany, United States and Netherlands. F. Heldmann's co-authors include Jürgen Braun, Joachim Sieper, Martín Rudwaleit, Joachim Listing, Hildrun Haibel, Xenofon Baraliakos, H. Küpper, Uta Kiltz, Robert Wong and Joseph M. Braun and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Arthritis & Rheumatology.

In The Last Decade

F. Heldmann

35 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Heldmann Germany 15 844 557 293 67 65 37 946
Michael Sejer Hansen Denmark 9 668 0.8× 249 0.4× 265 0.9× 59 0.9× 85 1.3× 12 755
Muhammad Asim Khan United States 9 1.1k 1.3× 501 0.9× 274 0.9× 85 1.3× 172 2.6× 13 1.2k
Ernst Feldtkeller Germany 12 1.3k 1.5× 634 1.1× 305 1.0× 66 1.0× 185 2.8× 27 1.4k
Mirjam K. de Vries Netherlands 8 409 0.5× 212 0.4× 108 0.4× 65 1.0× 29 0.4× 8 537
M Schneider Germany 7 481 0.6× 163 0.3× 140 0.5× 20 0.3× 37 0.6× 20 620
L.E. Burgers Netherlands 16 617 0.7× 126 0.2× 202 0.7× 45 0.7× 11 0.2× 23 724
Natalia Palmou‐Fontana Spain 13 280 0.3× 131 0.2× 127 0.4× 59 0.9× 34 0.5× 27 508
Fedra Irazoque-Palazuelos Mexico 10 464 0.5× 155 0.3× 180 0.6× 25 0.4× 14 0.2× 24 539
Pietro Leccese Italy 16 475 0.6× 190 0.3× 178 0.6× 99 1.5× 10 0.2× 49 739
D. Aletaha Austria 4 465 0.6× 211 0.4× 208 0.7× 13 0.2× 15 0.2× 4 524

Countries citing papers authored by F. Heldmann

Since Specialization
Citations

This map shows the geographic impact of F. Heldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Heldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Heldmann more than expected).

Fields of papers citing papers by F. Heldmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Heldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Heldmann. The network helps show where F. Heldmann may publish in the future.

Co-authorship network of co-authors of F. Heldmann

This figure shows the co-authorship network connecting the top 25 collaborators of F. Heldmann. A scholar is included among the top collaborators of F. Heldmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Heldmann. F. Heldmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfeil, Alexander, Christoph Baerwald, F. Heldmann, et al.. (2019). Rheumatologin/Rheumatologe in spe: Wie geht es weiter?. Zeitschrift für Rheumatologie. 79(2). 168–174. 8 indexed citations
2.
Keyßer, Gernot, Christoph Baerwald, Alexander Pfeil, et al.. (2019). Befragung von Rheumatologen in Sachsen, Sachsen-Anhalt und Thüringen zu Weiterbildungstätigkeit und beruflicher Situation: Kein Ausweg aus der rheumatologischen Unterversorgung. Zeitschrift für Rheumatologie. 78(5). 479–485. 15 indexed citations
3.
Kiltz, Uta, Xenofon Baraliakos, F. Heldmann, et al.. (2017). Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis – the TryCort study. Arthritis Research & Therapy. 19(1). 73–73. 6 indexed citations
4.
Baraliakos, Xenofon, F. Heldmann, Johanna Callhoff, et al.. (2016). Quantification of Bone Marrow Edema by Magnetic Resonance Imaging Only Marginally Reflects Clinical Neck Pain Evaluation in Rheumatoid Arthritis and Ankylosing Spondylitis. The Journal of Rheumatology. 43(12). 2131–2135. 5 indexed citations
5.
Braun, Juergen, et al.. (2015). Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes. Expert Review of Clinical Immunology. 11(8). 935–946. 13 indexed citations
6.
Braun, Juergen, Uta Kiltz, F. Heldmann, & Xenofon Baraliakos. (2015). Emerging drugs for the treatment of axial and peripheral spondyloarthritis. Expert Opinion on Emerging Drugs. 20(1). 1–14. 31 indexed citations
7.
Braun, Jürgen, Xenofon Baraliakos, Uta Kiltz, F. Heldmann, & Joachim Sieper. (2014). Classification and Diagnosis of Axial Spondyloarthritis — What Is the Clinically Relevant Difference?. The Journal of Rheumatology. 42(1). 31–38. 34 indexed citations
8.
Heldmann, F., Uta Kiltz, Xenofon Baraliakos, & Jürgen Braun. (2014). SAPHO-Syndrom. Zeitschrift für Rheumatologie. 73(8). 729–741. 4 indexed citations
9.
Baraliakos, Xenofon, Hildrun Haibel, Joachim Listing, et al.. (2013). Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years. Arthritis Research & Therapy. 15(3). R67–R67. 41 indexed citations
10.
Haibel, Hildrun, F. Heldmann, Jürgen Braun, et al.. (2013). Long‐Term Efficacy of Adalimumab After Drug Withdrawal and Retreatment in Patients With Active Non–Radiographically Evident Axial Spondyloarthritis Who Experience a Flare. Arthritis & Rheumatism. 65(8). 2211–2213. 36 indexed citations
11.
Baraliakos, Xenofon, N.T. Baerlecken, Torsten Witte, F. Heldmann, & Jürgen Braun. (2013). High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis. Annals of the Rheumatic Diseases. 73(6). 1079–1082. 65 indexed citations
12.
Fendler, C., et al.. (2012). Praktische Probleme bei der Umsetzung von Impfempfehlungen. Zeitschrift für Rheumatologie. 71(2). 147–155. 7 indexed citations
13.
Kiltz, Uta, F. Heldmann, Xenofon Baraliakos, & Jürgen Braun. (2012). Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition. Current Opinion in Rheumatology. 24(3). 252–260. 26 indexed citations
14.
Baraliakos, Xenofon, F. Heldmann, Joachim Listing, et al.. (2012). THU0262 Sclerostin does not predict radiographic progression in patients on anti-tnf therapy – new results from the european ankylosing spondylitis (AS) infliximab cohort (EASIC). Annals of the Rheumatic Diseases. 71. 243–243. 1 indexed citations
15.
Heldmann, F., Martín Rudwaleit, Hildrun Haibel, et al.. (2011). Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study. Annals of the Rheumatic Diseases. 70(6). 1108–1110. 124 indexed citations
16.
Heldmann, F., et al.. (2011). Perioperativer Umgang mit Biologika bei rheumatoider Arthritis. Zeitschrift für Rheumatologie. 70(1). 14–20. 8 indexed citations
17.
Baraliakos, Xenofon, F. Heldmann, D. van der Heijde, et al.. (2010). RADIOGRAPHIC FINDINGS AFTER 5 YEARS OF INFLIXIMAB TREATMENT IN PATIENTS WITH ANKYLOSING SPONDYLITIS. Clinical and Experimental Rheumatology. 28(4). 633–633. 1 indexed citations
18.
19.
Heldmann, F., et al.. (2010). Update on Biologic Therapy in the Management of Axial Spondyloarthritis. Current Rheumatology Reports. 12(5). 325–331. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Sejer Hansen Breakdown of academic impact, for papers by Muhammad Asim Khan Breakdown of academic impact, for papers by Ernst Feldtkeller Breakdown of academic impact, for papers by Mirjam K. de Vries Breakdown of academic impact, for papers by M Schneider Breakdown of academic impact, for papers by L.E. Burgers Breakdown of academic impact, for papers by Natalia Palmou‐Fontana Breakdown of academic impact, for papers by Fedra Irazoque-Palazuelos Breakdown of academic impact, for papers by Pietro Leccese Breakdown of academic impact, for papers by D. Aletaha
Rankless by CCL
2026